![](/img/cover-not-exists.png)
PGI2 USE OF DIFFERENT STATISTICAL APPROACHES TO COMPARE REAL-WORLD OUTCOMES ASSOCIATED WITH VEDOLIZUMAB VERSUS INFLIXIMAB IN BIOLOGIC-NAIVE PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Latremouille-Viau, D., Burne, R., Shi, S., Patel, H.Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.773
Date:
May, 2019
File:
PDF, 391 KB
english, 2019